Response of spatially defined microglia states with distinct chromatin accessibility in a mouse model of Alzheimer's

Alberto Ardura-Fabregat1,2, Lance Fredrick Pahutan Bosch1,2, Emile Wogram1

  • 1Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Nature Neuroscience
|July 14, 2025
PubMed

Insights

Non-plaque-associated microglia (non-PAM) in Alzheimer's disease (AD) are a dynamic state that transition to plaque-associated microglia (PAM). This transition, influenced by Csf1 signaling, offers potential therapeutic targets for AD.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Microglial spatial heterogeneity is critical for Alzheimer's disease (AD) pathogenesis.
  • Distinct microglia states near and far from amyloid-beta (Aβ) plaques and their roles in neurodegeneration are poorly understood.

Purpose of the Study:

  • To comprehensively characterize the relationship and dynamics between plaque-associated microglia (PAM) and non-plaque-associated microglia (non-PAM) in an AD mouse model.
  • To elucidate the contribution of distinct microglial states to AD progression.

Main Methods:

  • Multicolor fluorescence cell fate mapping
  • Single-cell transcriptional and epigenetic profiling
  • Immunohistochemistry and computational modeling

Main Results:

  • Non-PAM represent a distinct, dynamic microglial state that transitions to PAM following Aβ plaque deposition in female mice.
  • Non-PAM regulate cell population expansion in response to amyloid deposition and environmental cues.
  • Cerebrospinal fluid 1 (Csf1) signaling modulates the non-PAM to PAM transition during disease progression.

Conclusions:

  • Microglial states and their dynamic transitions play distinct roles in AD.
  • Targeting specific microglial states and their dynamics may offer novel therapeutic strategies for Alzheimer's disease.